Medical Disclaimer: This information is for educational purposes only. Never start, stop, or change opioid medications without medical supervision. Abrupt discontinuation can be dangerous. If you're concerned about your opioid use, speak with your healthcare provider.

Current Guidelines

Major medical organizations have shifted recommendations significantly based on growing evidence:

CDC 2022 Guidelines Key Points1

  • Non-opioid therapies should be tried first for chronic pain
  • If opioids are used, start with lowest effective dose
  • Avoid concurrent opioid and benzodiazepine prescribing
  • Evaluate benefits and risks within 1-4 weeks of starting
  • Individualized assessment is essential—no one-size-fits-all

The Complex Reality

The conversation about opioids for chronic pain is nuanced:

Limited Evidence for Long-Term Use

Studies show limited evidence that opioids improve pain and function long-term (>3 months) for most chronic pain conditions.2

Tolerance and Hyperalgesia

Over time, opioids may become less effective (tolerance) or paradoxically increase pain sensitivity (opioid-induced hyperalgesia).3

Some Patients Benefit

A subset of patients with chronic pain do experience meaningful, sustained benefit from opioid therapy when carefully monitored.4

Forced Tapering Harms

Rapidly tapering stable, long-term patients can cause serious harm, including worsened pain, withdrawal, and mental health crises.5

Risks of Long-Term Opioid Use

  • Dependence: Physical dependence develops with regular use (this is expected, not addiction)
  • Addiction: Compulsive use despite harm—risk is real but often overstated for patients with chronic pain
  • Overdose: Risk increases with higher doses and combination with other sedatives
  • Side effects: Constipation, sedation, cognitive effects, hormonal changes
  • Hyperalgesia: Paradoxical increased pain sensitivity
  • Falls: Increased risk, especially in older adults

Conditions Where Opioids May Be Considered

After non-opioid treatments have been tried:

  • Severe, disabling chronic pain significantly impacting quality of life
  • Cancer-related pain
  • Palliative care situations
  • Some patients with severe neuropathic pain
  • Patients who have demonstrated clear benefit with acceptable risks

Conditions Where Opioids Are Less Effective

  • Fibromyalgia: Not recommended—evidence shows poor efficacy, high risk6
  • Primary headache disorders: May worsen with overuse (medication overuse headache)
  • Functional abdominal pain: May worsen (narcotic bowel syndrome)

If You're Currently on Opioids

Working With Your Provider

  • Be honest about your pain, function, and any concerns
  • Take medications exactly as prescribed
  • Report side effects promptly
  • Store medications safely
  • Never share medications with others
  • Discuss naloxone (overdose reversal medication) with your provider

Monitoring

Your provider may:

  • Check prescription drug monitoring programs (PDMPs)
  • Request periodic urine drug screens
  • Assess function, not just pain levels
  • Require regular follow-up visits
  • Use treatment agreements

Tapering Opioids

Important Safety Information

Never stop opioids abruptly. Tapering must be done gradually under medical supervision. Rapid tapering has been associated with serious harm including suicide. If your provider suggests tapering, discuss a safe, individualized plan.

Appropriate Tapering

  • Should be gradual (typically 5-10% reduction per month for long-term use)7
  • Should be collaborative—patient and provider together
  • Should pause if withdrawal symptoms or increased pain are severe
  • May take months to years for those on high doses long-term
  • Should include support for managing pain with other approaches

When Tapering May Be Considered

  • Pain not improving despite opioids
  • Function declining
  • Side effects outweighing benefits
  • Patient preference to reduce/stop
  • Signs of opioid-induced hyperalgesia
  • High-risk situations (combining with benzodiazepines, history of overdose)

Alternatives and Complementary Approaches

Evidence-based treatments to use alongside or instead of opioids:

Emerging Treatments

New options on the horizon:

  • Non-opioid pain medications: New drug classes targeting pain without opioid receptors (e.g., CGRP inhibitors, sodium channel blockers)8
  • Medical cannabis: Legal in many states; evidence still emerging for chronic pain9
  • Ketamine therapy: For certain chronic pain conditions
  • Neuromodulation: Spinal cord and peripheral nerve stimulation

For Women Specifically

  • Pregnancy: Opioids during pregnancy can cause neonatal abstinence syndrome—discuss with OB
  • Breastfeeding: Some opioids pass into breast milk—individual risk/benefit assessment needed
  • Hormonal effects: Long-term opioids can affect menstrual cycles and fertility
  • Different metabolism: Women may metabolize some opioids differently than men

Track Your Medications

Document medication effectiveness, side effects, and function to inform discussions with your provider.

Get Symptom Diary

References

  1. Dowell D, et al. CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022. MMWR Recomm Rep. 2022;71(No. RR-3):1–95.
  2. Chou R, et al. The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(4):276-286.
  3. Lee M, et al. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14(2):145-161.
  4. Manhapra A, Becker WC. Pain and Addiction: An Integrative Therapeutic Approach. Med Clin North Am. 2018;102(4):745-763.
  5. Coffin PO, et al. Association of Opioid Dose Tapering With Subsequent Overdose and Mental Health Outcomes Among Patients With Chronic Pain. JAMA Netw Open. 2022;5(8):e2226454.
  6. Fitzcharles MA, et al. 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary. Pain Res Manag. 2013;18(3):119-126.
  7. HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-Term Opioid Analgesics. HHS Publication. 2019.
  8. Yekkirala AS, et al. Breaking barriers to novel analgesic drug development. Nat Rev Drug Discov. 2017;16(8):545-564.
  9. Aviram J, Samuelly-Leichtag G. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Pain Physician. 2017;20(6):E755-E796.

Related Resources